Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial
TG Jacobs, V Mumbiro, U Cassia… - Clinical Infectious …, 2024 - academic.oup.com
Background We evaluated dolutegravir pharmacokinetics in infants with human
immunodeficiency virus (HIV) receiving dolutegravir twice daily (BID) with rifampicin-based …
immunodeficiency virus (HIV) receiving dolutegravir twice daily (BID) with rifampicin-based …